- Home
- FULTP vs XGN Comparison
FULTP vs XGN Comparison
Compare FULTP & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FULTP
Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Current Price
Company Overview
Basic Information| Metric | FULTP | XGN |
|---|---|---|
| Founded | N/A | 2002 |
| Country | United States | United States |
| Employees | 3400 | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 64.5M |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | FULTP | XGN |
|---|---|---|
| Price | $18.17 | $3.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.14 |
| AVG Volume (30 Days) | 8.3K | ★ 287.8K |
| Earning Date | N/A | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $8.06 |
| Revenue Next Year | N/A | $12.93 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $2.59 |
| 52 Week High | $20.83 | $12.23 |
Technical Indicators
Market Signals| Indicator | FULTP | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 30.91 | 43.39 |
| Support Level | $17.73 | N/A |
| Resistance Level | $19.26 | $3.79 |
| Average True Range (ATR) | 0.39 | 0.21 |
| MACD | -0.05 | 0.02 |
| Stochastic Oscillator | 10.62 | 53.46 |
Price Performance
Historical ComparisonAbout FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.